The 2016 Omnibus Incentive Plan (the “2016 Plan”) has 8,000,000 shares authorized for issuance with 6,759,653 shares remaining at October 31, 2020. The 2016 Plan replaced the 2010 Long-Term Incentive Plan (the “2010 Plan”) in January 2017 in connection with our IPO. While no new awards will be granted under the 2010 Plan, awards previously issued under that plan that were outstanding as of the approval date of the 2016 Plan will remain outstanding and continue to be governed by the provisions of the 2010 Plan. The 2010 Plan has 1,109,686 shares remaining for issuance at October 31, 2020. The awards issued under the 2010 Plan that are currently outstanding are limited to stock options. These stock options are all fully vested and exercisable and have a contractual term of up to 10 years.

Under the 2016 Plan, officers, directors, including non-employee directors, and employees of the Company may be granted restricted stock awards (RSAs), restricted stock units (RSUs) or performance stock units (PSUs). Restricted stock awards and units generally vest over a one to four-year service period following the grant date, provided the recipient is still our employee, or non-employee director, at the time of vesting. Performance stock unit awards generally vest over a three to four-year service period following the grant date, provided the recipient is still our employee at the time of vesting, and provided the achievement of performance targets applicable to each award.

Stock-based compensation expense consists of vesting of restricted and performance stock units issued under the 2016 Plan and vesting of stock options issued under the 2010 Plan.

For fiscal years 2020, 2019, and 2018, the Company recorded stock-based compensation expense of $7.8 million, $7.2 million, and $6.3 million, respectively, as selling, general and administrative expenses in the Company’s Consolidated Statements of Operations and Comprehensive (Loss) Income. The actual income tax benefit realized totaled $1.8 million, $1.8 million, and $1.7 million for those same periods.

Restricted Stock Awards: The change in the number of nonvested restricted stock awards outstanding consisted of the following:

	Number of Awards			Weighted-Average Grant Date Fair Value Per Award
Nonvested, beginning of year		—		$	—
Granted		1,103,568			8.64
Vested		—			—
Forfeited		(420,651	)		11.68
Nonvested, end of year		682,917		$	6.76

As of October 31, 2020, the Company had $3.5 million of unrecognized compensation expense related to restricted stock awards, which will be recognized over a weighted-average period of 2.8 years.

Restricted Stock Units: The change in the number of nonvested restricted stock units outstanding consisted of the following:

	Number of Units			Weighted-Average Grant Date Fair Value Per Unit
Nonvested, beginning of year		1,394,205		$	11.94
Granted		307,127			10.81
Vested		(472,848	)		12.43
Forfeited		(308,223	)		11.91
Nonvested, end of year		920,261		$	11.42

The weighted average grant date fair value of restricted stock units granted during fiscal years 2019 and 2018 was $9.04 and $26.18, respectively. The total fair value of restricted stock units that vested during fiscal years 2020, 2019 and 2018 was $5.9 million, $3.5 million and $0.4 million, respectively.

As of October 31, 2020, the Company had $4.2 million of unrecognized compensation expense related to restricted stock awards, which will be recognized over a weighted-average period of 2.4 years.

Performance Stock Units: The change in the number of nonvested performance stock units consisted of the following:

	Number of Units			Weighted-Average Grant Date Fair Value Per Unit
Nonvested, beginning of year		48,734		$	27.36
Granted		507,003			5.23
Vested		(24,367	)		27.36
Forfeited		(80,000	)		6.74
Nonvested, end of year		451,370		$	6.16

No performance stock units were granted during 2019. The weighted average grant date fair value of performance stock units granted during fiscal year 2018 was $22.70. The total fair value of performance stock units that vested during fiscal years 2020 and 2019 was $0.7 million and $0.6 million, respectively. The total fair value of performance stock units that vested during fiscal year 2018 was immaterial.

As of October 31, 2020, the Company had $1.7 million of unrecognized compensation expense related to performance stock units, which will be recognized over a weighted-average period of 2.3 years.

	Number of Options			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value of Options
Outstanding, beginning of year		647,800		$	7.64		5.9	$	3,113
Granted		—			—		—		—
Exercised		(130,000	)		7.90		5.1		569
Forfeited		(10,000	)		8.11		—		7
Expired		(223,000	)		7.32		—		161
Outstanding, end of year		284,800		$	7.77		5.0	$	79
Exercisable, end of year		284,800		$	7.77		5.0	$	79

The aggregate intrinsic value above reflects the total pre-tax intrinsic value (the difference between the per share fair value of the Company’s stock and the exercise price of the stock options, multiplied by the number of in-the-money stock options) that would have been received by the option holders had all option holders exercised their options on October 31, 2020 and October 31, 2019. The intrinsic value of the Company’s stock options changes based on the changes in the share price of the Company’s common stock.

The total intrinsic value of stock options exercised during fiscal years 2020, 2019, and 2018, was $0.6 million, $0.5 million, and $26.8 million, respectively.

As of October 31, 2020, all outstanding options were completely vested so there was no unrecognized compensation expense related to stock options as of that date.